Article thumbnail

Streptococcus pneumoniae DNA Initiates Type I Interferon Signaling in the Respiratory Tract

By Dane Parker, Francis J. Martin, Grace Soong, Bryan S. Harfenist, Jorge L. Aguilar, Adam J. Ratner, Katherine A. Fitzgerald, Christian Schindler and Alice Prince


The mucosal epithelium is the initial target for respiratory pathogens of all types. While type I interferon (IFN) signaling is traditionally associated with antiviral immunity, we demonstrate that the extracellular bacterial pathogen Streptococcus pneumoniae activates the type I IFN cascade in airway epithelial and dendritic cells. This response is dependent upon the pore-forming toxin pneumolysin. Pneumococcal DNA activates IFN-β expression through a DAI/STING/TBK1/IRF3 cascade. Tlr4−/−, Myd88−/−, Trif−/−, and Nod2−/− mutant mice had no impairment of type I IFN signaling. Induction of type I IFN signaling contributes to the eradication of pneumococcal carriage, as IFN-α/β receptor null mice had significantly increased nasal colonization with S. pneumoniae compared with that of wild-type mice. These studies suggest that the type I IFN cascade is a central component of the mucosal response to airway bacterial pathogens and is responsive to bacterial pathogen-associated molecular patterns that are capable of accessing intracellular receptors

Topics: Research Article
Publisher: American Society of Microbiology
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (1998). A conserved tryptophan in pneumolysin is a determinant of the characteristics of channels formed by pneumolysin in cells and planar lipid bilayers.
  2. (2000). Additive attenuation of virulence of Streptococcus pneumoniae by mutation of the genes encoding pneumolysin and other putative pneumococcal virulence proteins.
  3. (2008). Airway epithelial cell signaling in response to bacterial pathogens.
  4. (2008). Alveolar epithelial STAT3, IL-6 family cytokines, and host defense during Escherichia coli pneumonia.
  5. (1998). Amino acid changes affecting the activity of pneumolysin alter the behaviour of pneumococci in pneumonia.
  6. (2004). Anthrolysin O and other gram-positive cytolysins are Toll-like receptor 4 agonists.
  7. (2006). Bacterial neuraminidase facilitates mucosal infection by participating in biofilm production.
  8. (1989). Contribution of autolysin to virulence of Streptococcus pneumoniae.
  9. (2000). Deficiency of T2K leads to apoptotic liver degenerationandimpairedNF-kappaB-dependentgenetranscription.EMBOJ.
  10. (2004). Differential requirement for TANK-binding kinase-1 in type I interferon responses to Toll-like receptor activation and viral infection.
  11. (2008). Distinct TLR-and NLR-mediated transcriptional responses to an intracellular pathogen.
  12. (2006). Epithelial cells are sensitive detectors of bacterial pore-forming toxins.
  13. (2008). Functional and phylogenetic characterization of vaginolysin, the human-specific cytolysin from Gardnerella vaginalis.
  14. (2008). Group A streptococcus activates type I interferon production and MyD88-dependent signaling without involvement of TLR2, TLR4, and TLR9.
  15. (2000). Host cellular immune response to pneumococcal lung infection in mice.
  16. (2004). IFN regulatory factor 3-dependent induction of type I IFNs by intracellular bacteria is mediated by a TLR- and Nod2-independent mechanism.
  17. (2008). Induction of CC and CXC chemokines in human antigen-presenting dendritic cells by the pneumococcal proteins pneumolysin and CbpA, and the role played by Toll-like receptor 4, NFkappaB, and mitogen-activated protein kinases.
  18. (2007). Interferon-induced Mx proteins in antiviral host defense.
  19. (2010). Intracellular DNA recognition.
  20. (2007). Murine nasal septa for respiratory epithelial air-liquid interface cultures.
  21. (2005). Myeloid differentiation factor 88-dependent signalling controls bacterial growth during colonization and systemic pneumococcal disease in mice.
  22. (2007). Nod1 mediates cytoplasmic sensing of combinations of extracellular bacteria.
  23. (2003). Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection.
  24. (2009). NOD2, RIP2 and IRF5 play a critical role in the type I interferon response to Mycobacterium tuberculosis.
  25. (2004). Phase variable desialylation of host proteins that bind to Streptococcus pneumoniae in vivo and protect the airway.
  26. (2009). Phosphatase-dependent regulation of epithelial mitogen-activated protein kinase responses to toxin-induced membrane pores. PLoS One 4:e8076.
  27. (2010). Pneumolysin activates the NLRP3 inflammasome and promotes proinflammatory cytokines independently of TLR4. PLoS
  28. (2004). Pneumolysin-induced lung injury is independent of leukocyte trafficking into the alveolar space.
  29. (2003). Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection.
  30. (2009). RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate.
  31. (1986). Role of interferon in streptococcal infection in the mouse.
  32. (2004). Role of Toll-like receptor 4 in gram-positive and gram-negative pneumonia in mice.
  33. (2008). Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization.
  34. (2009). Staphylococcus aureus activates type I IFN signaling in mice and humans through the Xr repeated sequences of protein
  35. (2009). STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity.
  36. (2009). Streptococcus pneumoniae nasopharyngeal colonization induces type I interferons and interferoninduced gene expression.
  37. (1944). Studies on the chemical nature of the substance inducing transformation of pneumococcal types: inductionsoftransformationbyadesoxyribonucleicacidfractionisolated from pneumococcus type III.
  38. (2005). Synergistic proinflammatoryresponsesinducedbypolymicrobialcolonizationofepithelial surfaces.
  39. TakaokaA,etal.2007.DAI(DLM-1/ZBP1)isacytosolicDNAsensorand an activator of innate immune response.
  40. (2008). TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines.
  41. (2005). The apoptotic response to pneumolysin is Toll-like receptor 4 dependent and protects against pneumococcal disease.
  42. (2002). The immune response to pneumococcalproteinsduringexperimentalhumancarriage.J.Exp.Med.
  43. (2008). The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease.
  44. (2004). The role of type I interferons in non-viral infections.
  45. (2007). The type I IFN response to infection with Mycobacterium tuberculosis requires ESX-1-mediated secretion and contributes to pathogenesis.
  46. (2005). The yin and yang of type I interferon activity in bacterial infection.
  47. (2007). Toll-like receptors and type I interferons.
  48. (2006). Type 1 interferons and the virus-host relationship: a lesson in détente.
  49. (2007). Type I IFN signaling is crucial for host resistance against different species of pathogenic bacteria.
  50. (2009). Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice.
  51. (2004). Type I interferon production enhances susceptibility to Listeria monocytogenes infection.
  52. (2007). Type I interferon signaling is required for activation of the inflammasome during Francisella infection.